legitscript-image
We are
Legitscript Certified
Click to Know More
Author Details
Written By
Dr. Swati Mishra
BDS
Reviewed By
Dr. Rajeev Sharma
MBA, MBBS
Last updated
29 Nov 2023 | 07:03 PM (IST)

We provide you with authentic, trustworthy and relevant information

Want to know more

Have issue with the content?

Report Problem

Molnunat 200mg Capsule

Prescription Required
Marketer
Natco Pharma Ltd
SALT COMPOSITION
Molnupiravir (200mg)
arrow
arrow

Product introduction

Molnunat 200mg Capsule is the first oral antiviral medication that helps treat mild to moderate COVID-19 in adults. It prevents the virus from multiplying, thereby reducing viral load and disease severity. The drug received emergency use approval from Indian drug regulatory authorities on December 28, 2021.

Molnunat 200mg Capsule is only indicated in patients with mild to moderate COVID-19 symptoms and who have a high risk of developing severe symptoms. The risk factors include obesity, older age (>60 years), diabetes mellitus, and heart diseases. It is not indicated in patients who require immediate hospitalization due to COVID-19. This drug has also been approved by the U.S. Food and Drug Administration (FDA) and the UK regulatory agency for emergency use.

Molnunat 200mg Capsule should be taken orally for no longer than 5 consecutive days. It is important to complete the entire 5 days of treatment, therefore do not stop taking it even if you feel better. The medicine may cause dizziness, headache, diarrhea, and nausea in some patients. If one experiences any such side effects, discuss them with the doctor. They may help with the treatment or suggest ways to prevent them.

Before taking Molnunat 200mg Capsule, let the doctor know if you have any pre-existing medical conditions. To make sure it is safe for you, inform your doctor about all the other medications you are taking. The use of Molnunat 200mg Capsule is not recommended in pregnant women. Pregnant and breastfeeding women should consult with their doctors before taking this medicine.

Uses of Molnunat Capsule

  • Treatment of Mild to moderate Coronavirus disease (COVID-19)

Benefits of Molnunat Capsule

In Treatment of Mild to moderate Coronavirus disease (COVID-19)

Molnunat 200mg Capsule helps manage mild to moderate Covid-19 symptoms in those individuals who are at a high risk of developing severe Covid-19 disease and do not need oxygen administration. This medicine may help you recover from the infection if diagnosed early before hospitalization. If you think you have come in contact with a person who has been infected with Covid-19, or if you feel any of these symptoms, consult your doctor immediately.

Side effects of Molnunat Capsule

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Molnunat

  • Nausea
  • Dizziness
  • Diarrhea

How to use Molnunat Capsule

Take this medicine in the dose and duration as advised by your doctor. Molnunat 200mg Capsule may be taken with or without food, but it is better to take it at a fixed time.

How Molnunat Capsule works

Molnunat 200mg Capsule is an antiviral medicine. It works by inhibiting the SARS-CoV-2 virus from replicating. This stops the virus from producing new copies and hence decreases the viral load in the body.

Safety advice

Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Molnunat 200mg Capsule. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Molnunat 200mg Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
UNSAFE
Molnunat 200mg Capsule is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving
CONSULT YOUR DOCTOR
It is not known whether Molnunat 200mg Capsule alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
SAFE IF PRESCRIBED
Molnunat 200mg Capsule is safe to use in patients with kidney disease. No dose adjustment of Molnunat 200mg Capsule is recommended.
Liver
SAFE IF PRESCRIBED
Molnunat 200mg Capsule is safe to use in patients with liver disease. No dose adjustment of Molnunat 200mg Capsule is recommended.

What if you forget to take Molnunat Capsule?

If you miss a dose of Molnunat 200mg Capsule, please consult your doctor.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine

Quick tips

  • Do not give Molnunat 200mg Capsule to children and adolescents aged less than 18 years.
  • Do not stop taking Molnunat 200mg Capsule without talking to your doctor first, as it will protect you from becoming severely ill from COVID-19.
  • Even after the treatment, continue practicing COVID-appropriate behavior such as wearing a mask, social distancing, and frequent handwashing.
  • For individuals with conceiving potential, it is advisable to use contraceptive methods while taking Molnupiravir and for 4 days after the last dose of the medicine.

Fact Box

Chemical Class
Cytosine Nucleotides
Habit Forming
No
Therapeutic Class
ANTI INFECTIVES
Action Class
Antiviral (Non-HIV) drugs

Interaction with drugs

Taking Molnunat with any of the following medicines can modify the effect of either of them and cause some undesirable side effects
Abacavir
Brand(s): Abamune, A-Bec
Life-threatening
Adefovir
Brand(s): Adesera, Adheb, Adfovir
Life-threatening
Didanosine
Brand(s): Dinex EC, Dinosin, Virosine DR
Life-threatening
Entecavir
Brand(s): Entehep
Life-threatening
View all interactions

Patient concerns

arrow
She has suffering from acute migraine for 3 to four days
Dr. Vikas Sharma
Neurology
do mri brain; take naxdom 1 bd fro 3v days then sos; tryptomer 19 mg hs10 mg instead of 19 mg
MORE
I got married 1 year ago we don't have a child yet what to do ?
Dr. Sonu Balhara Ahlawat
Obstetrics and Gynaecology
Wait for sometime u are only 19
MORE
arrow

FAQs

Q. Can Molnunat 200mg Capsule be given to children?

No, Molnunat 200mg Capsule is not approved for use in children or patients below the age of 18 years as it may interfere with the growth of bones and cartilage.

Q. What is the advantage of using Molnunat 200mg Capsule?

Molnunat 200mg Capsule has better patient compliance than some other treatment options available against COVID-19. Unlike other medicines that may need a skilled healthcare professional (a doctor or a nurse) to administer, Molnunat 200mg Capsule is an oral medicine that can be consumed by mouth in the dosage and schedule prescribed by the doctor.

Q. Are there any serious risks of taking Molnunat 200mg Capsule?

Yes, there are some serious risks involved with using Molnunat 200mg Capsule, including its potential to cause birth defects in pregnant women and serious damage to the growth of bones and cartilage (which may cause serious muscle damage). Therefore, Molnunat 200mg Capsule should be used only if prescribed by a doctor and not used for self-medication.

Q. Is taking Molnunat 200mg Capsule better than getting vaccinated?

No. There is no comparison between the two, and Molnunat 200mg Capsule is not a substitute for getting vaccinated. Vaccination is for prevention, while Molnunat 200mg Capsule is used to treat an existing COVID-19 infection, provided the infection is diagnosed at an early stage.

Q. Who is at a high risk of developing severe COVID-19?

People who are at a high risk of developing severe COVID-19 include those aged above 60 years, who are obese, have comorbid conditions including high blood pressure, diabetes, asthma, other medical conditions related to the lungs, kidneys (like dialysis patients), liver, or those who have a weak immunity (like cancer patients).

Q. Who should not take Molnunat 200mg Capsule?

Molnunat 200mg Capsule should not be taken to prevent COVID-19 or treat patients hospitalized due to COVID-19. According to the ongoing clinical trials, patients hospitalized with severe COVID-19 infection have not benefited from taking Molnunat 200mg Capsule.

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

  1. Molnupiravir [EMC SmPC]. London, UK: Merck Sharp & Dohme (UK) Limited; 2021. [Accessed 05 Jan. 2022] (online) Available from:External Link
  2. U.S. Food and Drug Administration: Center for Drug Evaluation and Research FDA Briefing Document, Antimicrobial Drugs Advisory Committee Meeting, November 30, 2021. [Accessed 05 Jan. 2022] (online) Available from:External Link
  3. Cipla receives Emergency Use Authorisation (EUA) to launch oral anti-viral drug Cipmolnu®(Molnupiravir 200mg) in India for treatment of adult patients with COVID-19, with SpO2>93% and with high risk of disease progression including hospitalization or death. Cipla: Press Statement. [Accessed 05 Jan. 2022] (online) Available from:External Link
  4. Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India. Sun Pharma: Press Release. [Accessed 05 Jan. 2022] (online) Available from:External Link
  5. Molnupiravir. U.S. Food & Drug Administration Antimicrobial Drugs Advisory Committee November 30, 2021. [Accessed 05 Jan. 2022] (online) Available from:External Link
  6. EUnetHTA Rolling Collaborative Review (RCR19) Authoring Team. Molnupiravir for the treatment of COVID-19. Diemen (The Netherlands): EUnetHTA; 2020. Report No.: RCR19, v1.0. [Accessed 05 Jan. 2022] (online) Available from:External Link
  7. Molnupiravir [Package leaflet: Information for the patient]. London, UK: Merck Sharp & Dohme (UK) Limited; 2021. [Accessed 05 Jan. 2022] (online) Available from:External Link
  8. European Medicines Agency. Assessment Report: Use of molnupiravir for the treatment of COVID-19. [Accessed 05 Jan. 2022] (online) Available from:External Link
  9. Kabinger F, Stiller C, Schmitzová J, et al. Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis. Nat Struct Mol Biol. 2021;28(9):740-746. [Accessed 05 Jan. 2022] (online) Available from:External Link
  10. FDA News Release. Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults. December 23, 2021. [Accessed 6th Jan. 2022] (online) Available from:External Link

Marketer details

Name: Natco Pharma Ltd
Address: Natco House, Road No.2, Banjara Hills, Hyderabad-500 034, India
Country of origin: India
₹1939
Inclusive of all taxes
MRP₹2000  3% OFF
40.0 capsules in 1 bottle
SOLD OUT
Notify me

INDIA’S LARGEST HEALTHCARE PLATFORM

260m+
Visitors
31m+
Orders Delivered
1800+
Cities
Get the link to download App

Connect

  • Social Links
  • Want daily dose of health?
Download App
Reliable

All products displayed on Tata 1mg are procured from verified and licensed pharmacies. All labs listed on the platform are accredited

Secure

Tata 1mg uses Secure Sockets Layer (SSL) 128-bit encryption and is Payment Card Industry Data Security Standard (PCI DSS) compliant

Affordable

Find affordable medicine substitutes, save up to 50% on health products, up to 80% off on lab tests and free doctor consultations.

LegitScript approved
India's only LegitScript and ISO/ IEC 27001 certified online healthcare platform

Know more about Tata 1mgdownArrow

Access medical and health information

Tata 1mg provides you with medical information which is curated, written and verified by experts, accurate and trustworthy. Our experts create high-quality content about medicines, diseases, lab investigations, Over-The-Counter (OTC) health products, Ayurvedic herbs/ingredients, and alternative remedies.

Order medicines online

Get free medicine home delivery in over 1800 cities across India. You can also order Ayurvedic, Homeopathic and other Over-The-Counter (OTC) health products. Your safety is our top priority. All products displayed on Tata 1mg are procured from verified and licensed pharmacies.

Book lab tests

Book any lab tests and preventive health packages from certified labs and get tested from the comfort of your home. Enjoy free home sample collection, view reports online and consult a doctor online for free.

Consult a doctor online

Got a health query? Consult doctors online from the comfort of your home for free. Chat privately with our registered medical specialists to connect directly with verified doctors. Your privacy is guaranteed.

© 2024 Tata 1mg. All rights reserved. All medicines are dispensed in compliance with the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. We do not process requests for Schedule X and habit forming drugs.